{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:12:34Z","timestamp":1758039154775,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:00:00Z","timestamp":1636156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ad.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T20:11:32Z","timestamp":1636575092000},"page":"973-975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adenocarcinoma apocrino cut\u00e1neo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab"],"prefix":"10.1016","volume":"113","author":[{"given":"J.","family":"Sola-Ortigosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mu\u00f1oz-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hern\u00e1ndez-Bronchud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Guilabert-Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2021.04.010_bib0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181590ba4","article-title":"Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases","volume":"32","author":"Robson","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2021.04.010_bib0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1600-0560.2008.01148.x","article-title":"Her-2\/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy","volume":"36","author":"Plaza","year":"2009","journal-title":"J Cut Path."},{"key":"10.1016\/j.ad.2021.04.010_bib0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.5021\/ad.2011.23.4.519","article-title":"Apocrine carcinoma of the groin possibly associated with extramammary Paget's disease","volume":"23","author":"Seo","year":"2011","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.ad.2021.04.010_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000478-198401000-00004","article-title":"Extramammary Paget's disease--evidence for an apocrine origin An immunoperoxidase study of gross cystic disease fluid protein-15, carcinoembryonic antigen, and keratin proteins","volume":"8","author":"Mazoujian","year":"1984","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.ad.2021.04.010_bib0075","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/DAD.0000000000000552","article-title":"Depth and patterns of adnexal involvement in primary Extramammary (anogenital) Paget Disease: a study of 178 lesions from 146 patients","volume":"38","author":"Konstantinova","year":"2016","journal-title":"Am J Dermatopathol."},{"key":"10.1016\/j.ad.2021.04.010_bib0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2021.04.010_bib0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000333002","article-title":"A case of metastatic extramammary Paget's disease responding to trastuzumab plus paclitaxel combination therapy","volume":"3","author":"Hanawa","year":"2011","journal-title":"Case Reports in Dermatology."},{"key":"10.1016\/j.ad.2021.04.010_bib0090","first-page":"401362","article-title":"Dramatic clinical response of relapsed metastatic extramammary Paget's disease to trastuzumab monotherapy","volume":"3","author":"Wakabayashi","year":"2012","journal-title":"Case Rep Dermatol Med."},{"key":"10.1016\/j.ad.2021.04.010_bib0095","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/mco.2017.1422","article-title":"Successful and long-term response to trastuzumab plus paclitaxel combination therapy in human epidermal growth factor receptor 2-positive extramammary Paget's disease: a case report and review of the literature","volume":"7","author":"Ichiyama","year":"2017","journal-title":"Mol Clin Oncol."},{"key":"10.1016\/j.ad.2021.04.010_bib0100","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3332\/ecancer.2018.840","article-title":"Are aggressive epithelial cancers \u201ca disease\u201d of Eutherian mammals?","volume":"12","author":"Bronchud","year":"2018","journal-title":"Ecancermedicalscience."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021004178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731021004178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:13:00Z","timestamp":1757553180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731021004178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0001731021004178"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2021.04.010","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenocarcinoma apocrino cut\u00e1neo inguinal con enfermedad de Paget extramamaria: respuesta a bloqueo dual HER2 con trastuzumab y pertuzumab","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}